PFIZER’s NORVASC APPROVED JULY 31 FOR HYPERTENSION, CHRONIC STABLE ANGINA AND VASOSPASTIC ANGINA; LAUNCH SLATED FOR EARLY FOURTH QUARTER

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".